$332.22 3.4 1.0%
Last Trade - 26/02/21
| Market Cap | £226.25bn |
| Enterprise Value | £244.84bn |
| Revenue | £184.57bn |
| Position in Universe | 23rd / 6715 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 157,107 | 184,840 | 201,159 | 226,247 | 242,155 | 257,141 | 278,602 | 302,783 | +10.4% | ||
| +5.5 | +20.6 | +31.1 | +28.3 | +17.5 | +11.9 | +14.4 | +13.8 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. OptumInsight provides services, technology and healthcare solutions to participants in the healthcare industry. OptumRx provides retail network contracting, purchasing and clinical solutions.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | July 1, 2015 |
| Public Since | October 17, 1984 |
| No. of Shareholders: | n/a |
| No. of Employees: | 325,000 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | Dow Jones Composite , Dow Jones Industrial Average , S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector), |
| Exchange | New York Stock Exchange |
| Shares in Issue | 948,820,710 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 9900 Bren Rd E, HOPKINS, 55343-9664, United States |
| Web | http://www.unitedhealthgroup.com/ |
| Phone | +1 952 9361300 |
| Contact | Frances Jacobs (IR Contact Officer) |
| Auditors | Deloitte & Touche LLP |
As of 26/02/21, shares in UnitedHealth Inc are trading at $332.22, giving the company a market capitalisation of £226.25bn. This share price information is delayed by 15 minutes.
Shares in UnitedHealth Inc are currently trading at $332.22 and the price has moved by 30.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the UnitedHealth Inc price has moved by 0.94% over the past year.
Of the analysts with advisory recommendations for UnitedHealth Inc, there are there are currently 9 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for UnitedHealth Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.
UnitedHealth Inc is scheduled to issue upcoming financial results on the following dates:
The UnitedHealth Inc dividend yield is 1.45% based on the trailing twelve month period.
Last year, UnitedHealth Inc paid a total dividend of 4.83, and it currently has a trailing dividend yield of 1.45%. Looking ahead, shares in UnitedHealth Inc are due to go ex-dividend on 2021-03-12 and the next dividend pay date is 2021-03-23.
UnitedHealth Inc are due to go ex-dividend on 2021-03-12 and the next dividend pay date is 2021-03-23. The historic dividend yield on UnitedHealth Inc shares is currently 1.45%.
To buy shares in UnitedHealth Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in UnitedHealth Inc are currently trading at $332.22, giving the company a market capitalisation of £226.25bn.
Here are the trading details for UnitedHealth Inc:
Based on an overall assessment of its quality, value and momentum, UnitedHealth Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in UnitedHealth Inc are currently priced at $332.22. At that level they are trading at 10.94% discount to the analyst consensus target price of 0.00.
Analysts covering UnitedHealth Inc currently have a consensus Earnings Per Share (EPS) forecast of 18.343 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UnitedHealth Inc. Over the past six months, the relative strength of its shares against the market has been -3.4%. At the current price of $332.22, shares in UnitedHealth Inc are trading at 3.7% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The UnitedHealth Inc PE ratio based on its reported earnings over the past 12 months is 20.73. The shares are currently trading at $332.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
UnitedHealth Inc's management team is headed by:
Here are the top five shareholders of UnitedHealth Inc based on the size of their shareholding:
